Who is sponsoring NCT06085352?

NCT06085352 is sponsored by Vance Thompson Vision.

What condition does NCT06085352 study?

NCT06085352 studies Ocular Pain.

What drugs are being tested in NCT06085352?

Interventions: TetraLens bandage contact lens, Control Acuvue Oasys Bandage contact Lens.

What is the status of NCT06085352?

NCT06085352 is currently COMPLETED.

Last reviewed 2025-09-17 · How we verify

Evaluate the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens in Patients Undergoing PRK Procedure

NCT06085352 EARLY_PHASE1 COMPLETED

The goal of this clinical trial is to determine the safety, efficacy, and comfort of the investigational TetraLens bandage contact lens in patients who have undergone photorefractive keratectomy (PRK). The main question\[s\] it aims to answer are: * Understand benefit of managing pain following the surgical procedure * Understand the safety of the Tetralens Participants will be asked to wear theTetraLens BCL in one eye for 6 days post-operatively and: document the daily quantity of oral analgesics needed and report ocular pain and contact lens comfort. Researchers will compare the study lens in one eye to a control lens in the contralateral (other eye)

Details

Lead sponsor	Vance Thompson Vision
Phase	EARLY_PHASE1
Status	COMPLETED
Enrolment	10
Start date	Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Jan 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Ocular Pain

Interventions

TetraLens bandage contact lens
Control Acuvue Oasys Bandage contact Lens

Countries

United States